U.S. flag

An official website of the United States government, Department of Justice.

Overdose Fatality Review Enhancement

Award Information

Award #
Funding Category
Competitive Discretionary
Congressional District
Funding First Awarded
Total funding (to date)

Description of original award (Fiscal Year 2016, $600,000)

In FY 2016, the Harold Rogers Prescription Drug Monitoring Program (PDMP) will provide funding to state agencies and units of local government located in states with existing and operational prescription drug monitoring programs, and federally recognized Indian tribal governments (as determined by the Secretary of the Interior).

Funding may be used to form multi-disciplinary action groups consisting of local, state, and federal criminal justice professionals in addition to state and local health authorities as well treatment providers. Action group members may include (but are not limited to): district attorney’s office, state or local health department, state medical and pharmacy boards, police and sheriff departments, probation and parole, local drug treatment providers, and community organizations. The action groups will collect data from various sources such as medical examiners, emergency rooms, crime data, and other relevant sources that can help to corroborate PDMP data as well as provide additional information to help pinpoint specific locations within the county that are at-risk for prescription drug abuse and drug overdose deaths. Grant activities should focus on data sharing arrangements, data collection, and analysis. Project plan should describe the type of strategies to be developed and the areas (e.g., prevention, treatment, regulatory activity, enforcement) in which the action group plans to have impact to address prescription drug abuse rates in a defined jurisdiction(s). It is anticipated that grantees will determine best practices for sharing data, establishing effective policy and regulatory schemes, supporting investigations, treatment intervention, and prevention efforts for at-risk individuals and communities. Data should be used to identify areas at greatest risk for prescription drug abuse and overdose deaths and create data-driven responses at the local or state level to include education, outreach, treatment, and enforcement.

Date Created: September 20, 2016